Navigation Links
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Date:5/26/2009

rmulation of CK-1827452 in patients with ischemic cardiomyopathy and angina. Cytokinetics also plans to present data from this trial at the 2009 Heart Failure Congress of the European Society of Cardiology. Top-line data from this trial were included in a Cytokinetics press release in December 2008. The third Phase 2a clinical trial is designed to evaluate an intravenous formulation of CK-1827452 in patients with stable heart failure undergoing clinically indicated coronary angiography in the cardiac catheterization laboratory. Cytokinetics recently initiated its fourth Phase 2a clinical trial of CK-1827452, an open-label, multi-center, multiple-dose trial designed to evaluate and compare the oral pharmacokinetics of both a modified release and an immediate release formulation of CK-1827452 in patients with stable heart failure.

In addition, Cytokinetics has conducted five Phase 1 clinical trials of CK-1827452 in healthy subjects: a first-time-in-humans study evaluating an intravenous formulation, an oral bioavailability study evaluating both intravenous and oral formulations, and three studies of oral formulations: a drug-drug interaction study, a dose proportionality study and a study evaluating modified-release formulations. Data from each of these trials have been reported previously.

Background on Cardiac Myosin Activators and Cardiac Contractility

Cardiac myosin is the cytoskeletal motor protein in the cardiac muscle cell that is directly responsible for converting chemical energy into the mechanical force resulting in cardiac contraction. Cardiac contractility is driven by the cardiac sarcomere, a highly ordered cytoskeletal structure composed of cardiac myosin, actin and a set of regulatory proteins, and is the fundamental unit of muscle contraction in the heart. The sarcomere represents one of the most thoroughly characterized protein machines in human biology. Current inotropic agents, such as beta-ad
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Amgen Announces Voting Results Of Annual Meeting Of Stockholders
2. Photos: Amgen and ONSEdge Partner With Cancer Survivor Jan Ping for New Campaign
3. Preclinical Data From Amgens Oncology Pipeline to be Presented at AACR
4. Amgen to Present at the Cowen and Company Annual Healthcare Conference
5. FDA Accepts Amgens Submission and Files Biologics License Application for Denosumab
6. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
7. Amgens Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
8. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
9. Amgen to Present at the 27th Annual JP Morgan Healthcare Conference
10. Amgen Foundation Announces $2.5 Million Expansion of Amgen Scholars Program to Europe
11. Amgen Positioned to Deliver Attractive Growth Over Next Five Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... CALGARY, Dec. 11 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ... today announced the appointment of Dr. Alan Warrander ... Licensing and Business Development. ,, "Dr. Warrander will ... licensing strategy for REOLYSIN(R)," said Dr. Brad Thompson, ... agreement on the design of a Phase 3 ...
(Date:12/10/2009)... Dec. 10 Microban International, Ltd., ... protection, has partnered with Sharp Imaging and ... Sharp Electronics, to incorporate it,s third generation ... calculators. Infused into the calculator keys during ... the growth of damaging bacteria on the ...
(Date:12/10/2009)... economy and markets exhibiting continued signs of growth, Sidoti ... research provider, will seek to educate investors on a ... market at the firm,s First 2010 Micro Cap ... Hyatt Hotel in New York, NY. ,, ... of Wall Street, but the well-informed investor has the ...
(Date:12/10/2009)... a world-leading provider of advanced flow measurement, control, ... join the company as Global Level Product Manager ... Instrument’s efforts to enhance market penetration of the ... joining Brooks Instrument from Lafarge Corp, a manufacturer ... of Marketing and Sales. Bayda will report to ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... Fourth Consecutive Year, INDIANAPOLIS, Oct. 7 ... the magazine,s Top 500 innovative users of,technology, ... of companies in the biotech,and pharmaceutical industry., ... in the 2008 report,outperformed others in business-process ...
... 7 Vical Incorporated (Nasdaq:,VICL) and AnGes MG, ... their mutual interest to license the development and ... Japan to AnGes. AnGes,plans to conduct due diligence ... intend to negotiate terms and conditions potentially leading,to ...
... chemistry and introducing continuous process chemistry to the ... next generation of chemists among the ... 6 ,ThalesNano, Inc. today announced that it has signed ... Research Institute,the University of California, San Francisco, Boston University, ...
Other Biology Technology:InformationWeek Puts Roche Diagnostics on Top 500 Innovative Tech Users List 2Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program 2ThalesNano, Inc. Forms Collaborations with Leading US Universities based on the Award Winning H-Cube(R) and H-Cube Midi(TM) 2
(Date:12/14/2009)... HAMILTON, ON, December 10, 2009If you are spending the ... and wondering whether you would be better off with ... fish. , A research team from McMaster University ... that among cichlids, a species that lives in groups, ... , The results appear in the current issue of ...
(Date:12/14/2009)... is in preventing some of the stresses of open surgery ... flow and organ dysfunction. Laparoscopy is a type of surgery ... , By adding another gas to the carbon dioxide ... Duke University Medical Center have found they can preserve more ... ethyl nitrite (ENO) helped to open blood vessels and keep ...
(Date:12/13/2009)... 10, 2009Researchers at The Scripps Research Institute have ... protein from an ancient family of enzymes can ... In addition to providing guidance for understanding other ... theoretical underpinning for the protein,s possible use for ... The research was published in the December 13, ...
Breaking Biology News(10 mins):Gas improves blood flow and organ status during minimally invasive surgery 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Novel detection method unmasks circulating breast cancer cells 63168 1Novel detection method unmasks circulating breast cancer cells 63168 2Novel detection method unmasks circulating breast cancer cells 63168 3Stem Cells Turned Into AIDS Killers in Lab Tests 63165 1Effort to Regenerate Injured Spinal Cords Turns to a New Model 63160 1Effort to Regenerate Injured Spinal Cords Turns to a New Model 63160 2Effort to Regenerate Injured Spinal Cords Turns to a New Model 63160 3Effort to Regenerate Injured Spinal Cords Turns to a New Model 63160 4
... German . , The "Large Molecule ... star forming region Sagittarius B2. In this source of only ... newly formed star, most of the interstellar molecules known to ... as ethyl alcohol, formaldehyde, formic acid, acetic acid, glycol aldehyde ...
... ARBOR, Mich.---University of Michigan researchers are investigating a radical ... tanks, the water-filled compartments that enable non-native creatures to ... least 185 non-native aquatic species have been identified in ... the introduction of most---including the notorious zebra and quagga ...
... U.S. Department of Homeland,Security (DHS) announced today ... international visitors arriving at New York,s John ... part of the department,s,upgrade from two- to ... travel by more accurately and efficiently,establishing and ...
Other Biology News:New organic molecule in space 2U-M 'ballast-free ship' could cut costs while blocking aquatic invaders 2U-M 'ballast-free ship' could cut costs while blocking aquatic invaders 3DHS Begins Collecting 10 Fingerprints From International Visitors at New York's John F. Kennedy International Airport 2
... Vector is specifically designed to target and ... Saccharomyces cerevisiae. Displayed proteins can be analyzed ... or putative ligands. pYD1 uses the a-agglutinin ... domains Aga1 and Aga2 to display recombinant ...
... 15(S)-15-methyl PGF2α is a metabolically ... is a potent uterine stimulant ... administered intramuscularly to induce labor. ... serum progesterone concentrations when given ...
... media are neutral, porous styrene ... chromatography of lipophilic polymers and ... eluents. The beads are compatible ... tetrachloride, dimethylformamide, ketones, aromatics, methylene ...
... Epitope: A BALB/c mouse was ... Recommended Storage: Store vial at -20 C ... at -20 C or below for extended storage. ... Centrifuge product if not completely clear after standing ...
Biology Products: